Company · CIK 0001821323
Sigilon Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/ASigilon Therapeutics, Inc.0001193125-24-036373 · 109.0 KBSEC(opens sec.gov)
- SC 13D/ASigilon Therapeutics, Inc.0001193125-23-212400 · 76.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-210739 · 289.6 KBSEC(opens sec.gov)
- 10-QQuarterly update0001558370-23-013494 · 7.2 MBSEC(opens sec.gov)
- SC 13DSigilon Therapeutics, Inc.0001193125-23-183831 · 160.9 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-23-076070 · 1.2 MBSEC(opens sec.gov)
- 8-KCurrent report0001558370-23-010309 · 213.4 KBSEC(opens sec.gov)
- 10-QQuarterly update0001558370-23-008685 · 6.2 MBSEC(opens sec.gov)
- 8-KCurrent report0001558370-23-008667 · 339.5 KBSEC(opens sec.gov)
- 10-KAnnual report0001558370-23-003716 · 11.6 MBSEC(opens sec.gov)
Insiders
- AFEYAN NOUBAR10% Owner
- ANDERSON DANIEL GRIFFITHDirector
- Ashton-Rickardt PhilipCHIEF SCIENTIFIC OFFICER
- Cole Douglas G.Director
- CORZO DEYACHIEF MEDICAL OFFICER
- Cox JohnDirector
- ELI LILLY & Co10% Owner
- Flagship Pioneering, LLC10% Owner
- Flagship Ventures Fund V General Partner LLC10% Owner
- Flagship Ventures Fund V, L.P.10% Owner
Tickers
No tickers on record.
Addresses
business
100 BINNEY STREET STE 600
CAMBRIDGE, MA, 02142
mailing
100 BINNEY STREET STE 600
CAMBRIDGE, MA, 02142
Same industry